Aldeyra Therapeutics to Present at Upcoming Healthcare Investor Conferences
November 12 2019 - 8:00AM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases, today announced that Todd C. Brady, M.D.,
Ph.D., President and CEO of Aldeyra, will present at the following
healthcare investor conferences in November:
- Stifel 2019 Healthcare Conference Lotte New York Palace
Hotel New York, N.Y. Tuesday, November 19, 2019 Presentation
time: 4:45 p.m. (ET)
- Jefferies 2019 London Healthcare Conference London, U.K.
Thursday, November 21, 2019 Presentation time: 11:40 a.m.
(ET)/4:40 p.m. (GMT)
Live audio webcasts of these presentations can be accessed on
the Investor Relations section of the Aldeyra Therapeutics website
at https://ir.aldeyra.com. Replays will be available following the
live events and will be archived on the website for 90 days.
About Aldeyra Therapeutics Aldeyra Therapeutics is a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases. Aldeyra's lead investigational drug
product candidates are first-in-class potential treatments in
development for dry eye disease, allergic conjunctivitis,
proliferative vitreoretinopathy, and Sj�gren-Larsson Syndrome. The
company is also developing other product candidates for retinal and
systemic inflammatory diseases.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191112005614/en/
Corporate Contact: David McMullin Aldeyra Therapeutics,
Inc. Tel: 781-761-4904 ext. 218 dmcmullin@aldeyra.com
Investor & Media Contact: Scott Solomon Sharon
Merrill Associates, Inc. Tel: 617-542-5300
ALDX@investorrelations.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2023 to Apr 2024